4.6 Article

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Adiponectin, T-cadherin and tumour necrosis factor-α in damaged cardiomyocytes from autopsy specimens

T Takahashi et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2005)

Article Physiology

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

CR Trillou et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)

Article Biochemistry & Molecular Biology

Cloning and molecular characterization of the rat CB2 cannabinoid receptor

SM Brown et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)